Trial Profile
Safety, efficacy and prognostic analyses of sunitinib in the post-marketing surveillance study of Japanese patients with gastrointestinal stromal tumor
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Feb 2016
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Adverse reactions; Therapeutic Use
- 24 Feb 2016 New trial record